Cargando…
The Benefits of Family Screening in Rare Diseases: Genetic Testing Reveals 165 New Cases of Fabry Disease among At-Risk Family Members of 83 Index Patients
Background: Fabry disease (FD, OMIM #301500) is a rare, progressive, X-linked, inherited genetic disease caused by a functional deficiency of lysosomal α-galactosidase, leading to the accumulation of glycosphingolipids in virtually all of the body’s cell types and fluids. Patients with rare genetic...
Autores principales: | Moiseev, Sergey, Tao, Ekaterina, Moiseev, Alexey, Bulanov, Nikolay, Filatova, Ekaterina, Fomin, Victor, Germain, Dominique P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498688/ https://www.ncbi.nlm.nih.gov/pubmed/36140787 http://dx.doi.org/10.3390/genes13091619 |
Ejemplares similares
-
Sex differences in mortality in the intensive care unit patients with severe COVID-19
por: Moiseev, Sergey, et al.
Publicado: (2021) -
The benefits and challenges of family genetic testing in rare genetic diseases—lessons from Fabry disease
por: Germain, Dominique P., et al.
Publicado: (2021) -
Fabry disease
por: Germain, Dominique P
Publicado: (2010) -
Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma
por: Zhang, Jing-Tao, et al.
Publicado: (2019) -
Screening of family members of chronic kidney disease patients with Fabry disease mutations: a very important and underrated task
por: Sodré, Luciana Senra de Souza, et al.
Publicado: (2020)